Abstract
Background Systematic reviews require extensive time and effort to manually extract and synthesize data from numerous screened studies. This study aims to investigate the ability of large language models (LLMs) to automate data extraction with high accuracy and minimal bias, using clinical questions (CQs) of the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock (J-SSCG) 2024. the study will evaluate the accuracy of three LLMs and optimize their command prompts to enhance accuracy.
Methods This prospective study will objectively evaluate the accuracy and reliability of the extracted data from selected literature in the systematic review process in J-SSCG 2024 using three LLMs (GPT-4 Turbo, Claude 3, and Gemini 1.5 Pro). Detailed assessment of errors will be determined according to the predefined criteria for further improvement. Additionally, the time to complete each task will be measured and compared among the three LLMs. Following the primary analysis, we will optimize the original command with integration of prompt engineering techniques in the secondary analysis.
Trial registration This research is submitted with the University hospital medical information network clinical trial registry (UMIN-CTR) [UMIN000054461].
Conflicts of interest All authors declare no conflicts of interest to have.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://center6.umin.ac.jp/cgi-bin/ctr/ctr_view_reg.cgi?recptno=R000062206
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
